Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2

Infection and Immunity

Volumn 64, Issue 12, 1996, Pages 5053-5060

  Fujii, Jun ^a   Kinoshita, Yoshimasa ^a   Kita, Toshiro ^a   Higure, Aiichiro ^a   Takeda, Tae ^b   Tanaka, Noriyuki ^a   Yoshida, Shin Ichi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VEROTOXIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INJURY; CONTROLLED STUDY; EPENDYMA CELL; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HISTOPATHOLOGY; MALE; MORTALITY; MYELIN SHEATH; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT;

EID: 0029806691     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.12.5053-5060.1996     Document Type: Article

References (41)

1. Akashi, S., K. Joh, A. Tsuji, H. Ito, H. Hoshi, T. Hayakawa, J. Ihara, T. Abe, M. Hitori, T. Mori, and T. Nakamura. 1994. A severe outbreak of haemorrhagic colitis and haemolytic uraemic syndrome associated with Escherichia coll O157:H7 in Japan. Eur. J. Pediatr. 153:650-655.
2. Babb, T. L., and W. J. Brown. 1987. Pathological finding in epilepsy, p. 511-540. In J. Engl (ed.), Surgical treatment of the epilepsies. Raven Press, New York.
3. Barrett, T, J., M. E. Potter, and I, K. Wachsmuth. 1989. Continuous peritoneal infusion of Shiga-like toxin II (SLTII) as a model for SLT II-induced disease. J. Infect. Dis. 159:774-777.
4. Bridgwater, F. A. J., R. S. Morgan, K. E. K. Rowson, and G. P. Wright. 1955. The neurotoxin of Shigella shigae. Morphological and functional lesions produced in the central nervous system of rabbits. Br. J. Exp. Pathol. 36:447-453.
5. Francis, D. H., R. A. Moxley, and C. Y. Andraos. 1989. Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli scrotype O157:H7. Infect. Immun. 57:1339-1342.
6. Fujii, J., T. Kita, S. Yoshida, T. Takeda, H. Kobayashl, N. Tanaka, K. Ohsato, and Y. Mizuguchi. 1994. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect. Immun. 62:3447-3453.
7. Hamano, S., Y. Nakanishi, T. Nara, T. Seki, T. Ohtani, T. Oishi, K. Joh, T. Oikawa, Y. Muramatsu, Y. Ogawa, and S. Akashi. 1993. Neurological manifestations of hemorrhagic colitis in the outbreak of Escherichia coli O157:H7 infection in Japan. Acta Paediatr. 82:454-458.
8. Hammond, E. J., and B. J. Wilder. 1985. Gamma-vinyl GABA. Gen. Pharm. 16:441-447.
9. Hii, J. H., C. Gyles, T. Morooka, M. A. Karmali, R. Clarke, S. DeGrandis, and J. L. Brunton. 1991. Development of verotoxin 2- and verotoxin 2 variant (VT2v)-specitic oligonucleotlde probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1. J. Clin. Microbiol. 29:2704-2709.
10. Howard, J. G. 1955. Observations on the intoxication produced in mice and rabbits by the neurotoxin of Shigella shigae. Br. J. Exp. Pathol. 36:439-446.
11. Jackson, M. P., R. J. Neill, A. D. O'Brien, R. K. Holmes, and J. W. Newland. 1987. Neucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. FEMS Microbiol. Lett. 44:109-114.
12. Karmali, M. A. 1989. Infection by verocytotoxin-producing Escherichia coli, Clin. Microbiol. Rev. 2:15-38.
13. Karmall, M. A., M. Petric, C. Lim, P. C. Fleming, G. S. Arbus, and H. Lior. 1985. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J. Infect. Dis. 151:775-782.
14. Karmali, M. A., B. T. Steele, M. Petric, and C. Lim. 1983. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotnxin and cytotoxin-producing Escherichia coli in stools. Lancet 1:619-620.
15. Karnovsky, M. J. 1967. The ultrastructural basis of capillary permeability studied with peroxidase as a tracer. J. Cell. Biol. 35:213-236.
16. Kobayashi, N. 1986 Ekiri, an acute encephalopathy associated with dysentery in Japanese children: a review in retrospect. Acta Paediatr. Jpn. 28:651-655.
17. Linggood, M. A., and J. M. Thompson. 1987. Verotoxin production among porcine strains of Escherichia coli and its association with oedema disease. J. Med. Microbiol. 25:359-362.
18. Lingwood, C. A., H. Law, S. Richardson, M. Petric, J. L. Brunton, S. DeGrandis, and M. A. Karmall. 1987. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro, J. Biol. Chem. 262:8834-8839.
19. Liu, L., T. Kita, N. Tanaka, and Y. Kinoshita. 1996. The expression of tumor necrosis factor in the hypothalamus after treatment with lipopolysaccharide. Int. J. Exp. Pathol. 77:37-44.
20. Lukes, S. A., L. E. Crooks, M. J. Aminoff, L. Kaufman, H. S. Panitch, C. Mills, and D. Norman. 1983. Nuclear magnetic resonance imaging in multiple sclerosis. Ann. Neurol. 13:592-601.
21. Milford, D. V., C. M. Taylor, B. Gutiridge, S. M. Hall, B. Rowe, and H. Kleanthous. 1990. Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. 1. Clinical and epidemiological aspects. Arch. Dis. Child. 65:716-721.
22. Morrison, D. M., D. L. J. Tyrrell, and L. D. Jewell. 1986. Colonic biopsy in verotuxin-induced hemorrhagic coiitis and thrombutic thrombocytopenic purpura (TTP). Am. J. Clin. Pathol. 86:108-112.
23. Orme, S. F., E. Clark, and R. L. Siegler. 1994. Neuropsychological sequelae of the hemolytic uremic syndrome, abstr. P4.21, p. 88, In Abstracts of the 2nd International Symposium and Workshop on Verocytotoxin (Shiga-Like Toxin)-Producing Escherichia coli Infections. Bergamo. Italy.
24. Ostroff, S. M., P, I. Tarr, M. A. Neill, J. H. Lewis, N. Hargrett-Bean, and J. M. Kobayashi. 1989. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J. Infect. Dis. 160:994-998.
25. Richardson, S. E., T. A. Rotman, V. Jay, C. R. Smith, L. E. Becker, M. Petric., N. F. Olivieri, and M. A. Karmall. 1992. Experimental verocytotoxemia in rabbits. Infect. Immun. 60:4154-4167.
26. Riet-Correa, F., M. D. C. Mendez, A. L. Schild, B. A, Summers, and J. A. Ollveira. 1983. Intoxication by Solanum fastigiatum var. fastigiatum as a cause of cerebellar degeneration in cattle, Cornell Vet. 73:240-256.
27. Riley, L. W., R. S. Remis, S. D. Heigerson, H. B. McGee, J. G. Wells, B. R. Davis, R. J. Hebert, E. S. Olcott, L. M. Johnson, N. T. Hargrett, P. A. Blake, and M. L. Cohen. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685.
28. Rooney, J. C., R. M. Anderson, and I. J. Hppkins. 1971. Clinical and pathological aspects of central nervous system involvement in the haemolytic uraemic syndrome. Aust. Paediatr. J. 7:28-33.
29. Shi, Z.-R., S. H. Itzkowitz, and Y. S. Kim. 1988. A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J. Histochem. Cytochem. 36:317-322.
30. Spencer, P. S., G. V. Foster, A. B. Sterman, and D. Horoupian. 1980. Acetyl ethyl tetramethyl tetralin, p. 296-308. In P. S. Spencer and H. H. Schaumburg (ed.). Experimental and clinical neurotoxicology. The Williams & Wilkins Co., Baltimore.
31. Strockbine, N. A., M. P. Jackson, L. M. Sung, R. K. Holmes, and A. D. O'Brien. 1988. Cloning and sequencing of genes for Shiga toxin from shigella dysenteriae type 1. J. Bacteriol. 170:1116-1122.
32. Takao, T., T. Tanabe, Y.-M. Hong, Y. Shimonishi, H. Kurazono, T. Yutsudo, C. Sasakawa, M. Yoshikawa, and Y. Takeda. 1988. Identity of molecular structure of Shiga-like. toxin 1 (VT1) from Escherichia coli O157: H7 with that of Shiga toxin. Microb. Pathog. 5:357-369.
33. Tesh, V. L., J, E. Samuel, L. P. Perera, J. B. Sharefkin, and A. D. O'Brien. 1991. Evaluation of the role of Shiga and Shign-like toxins in mediating direct damage to human vascular endothelial cells. J. Infect. Dis. 164:344-352.
34. Towfight, J. 1980. Hexachloruphene, p. 440-455. In P. S. Spencer and H. H. Schaumburg (ed.), Experimental and clinical neuroloxicology. The Williams & Wilkins Co., Baltimore.
35. Tyler. S. D., W. M. Johnson, H. Lior, G. Wang, and K, R. Rozee. 1991. Identification of verotuxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis. J. Clin. Microbiol. 29:1339-1343.
36. Tzipori, S., C. W. Chow, and H. R. Powell. 1988. Cerebral infection with Eschericha coli O157:H7 in humans and gnotobiotic piglets. J. Clin. Pathol. 41:1099-1103.
37. Upadhyaya, K., K. Barwick, M. Fishaut, M. Kashgarian, and N. J. Siegel. 1980. The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics 65:115-120.
38. Waddell, T., S. Head, M. Petric, A. Cohcn, and C. Lingwood. 1988. Globotriosyl ceramide is specifically recognized by the Encherichia coli verotoxin 2. Biochem. Biophys. Res. Commun. 152:674-679.
39. Weinstein, D. L., M. P. Jackson, J. E. Samuel, R. K. Holmes, and A. D. O'Brien. 1988. Cloning and sequencing of a Shiga-like toxin type II variant from an Eseherichia coli strain responsible for edema disease of swine. J. Bacteriol. 170:4223-4230.
40. Yutsudo, T., N. Nakabayashi, T. Hirayama, and Y. Takeda. 1987. Purification and some properties of a vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb. Pathog. 3:21-30.
41. Zoja, C., D. Corna, C. Farina, G. Sacchi, C. Lingwood, M. P. Doyle, V. V. Padhye, M. Abbate, and G. Remuzzi. 1992. Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1. J. Lab. Clin. Med. 120:229-238.